Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 9481Neoplasms 6589Prostatic Neoplasms 4399Colorectal Neoplasms 3978Lung Neoplasms 3644Carcinoma, Non-Small-Cell Lung 3585Pancreatic Neoplasms 2479Carcinoma, Hepatocellular 2413Leukemia, Myeloid, Acute 2265Multiple Myeloma 2121Stomach Neoplasms 2109Neoplasm Metastasis 1911Head and Neck Neoplasms 1870Ovarian Neoplasms 1773Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Brain Neoplasms 1702Rectal Neoplasms 1676Melanoma 1656Colonic Neoplasms 1629Leukemia 1500Uterine Cervical Neoplasms 1499Recurrence 1486Esophageal Neoplasms 1312Glioblastoma 1308Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

anlotinib 1S 1 (combination) 1Oxaliplatin 1Irinotecan 1Immune Checkpoint Inhibitors 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Overall Survival × Clear all
NCT03726021 2023-03-29

Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

Qingdao Central Hospital

Phase 2 Completed
47 enrolled

Overall Survival

NCT05218629 2023-03-29

Anlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic Cancer

Qingdao Central Hospital

Phase 2 Unknown
20 enrolled

Overall Survival

NCT03275376 2021-03-16

Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma

Taichung Veterans General Hospital

Phase 2 Terminated
34 enrolled

Overall Survival

NCT04050787 2019-08-08

Spleen-Preserving No. 10 Lymph Node Dissection in Gastric Cancer

The First Hospital of Jilin University

Phase NA Unknown
100 enrolled

Overall Survival

Data powered by HemOnc (CC BY 4.0) Colophon âš¡